Prospective study for predictive biomarkers and modified risk scoring model for venous thromboembolism in Japanese patients with unresectable or metastatic cancer. - PRiDICT study

Clinical Research Center, Saga University Hospital0 sites240 target enrollmentApril 1, 2017

Overview

Phase: 未知
Intervention: Not specified
Conditions: lung cancer, esophageal cancer, gastric cancer, biliary tract cancer, pancreatic cancer, colorectal cancer
Sponsor: Clinical Research Center, Saga University Hospital
Enrollment: 240
Status: Completed
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

April 1, 2017

End Date

March 31, 2021

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

Clinical Research Center, Saga University Hospital

•1\. Patients have history of VTE in the past. 2\. Patients have recently received radiotherapy except for palliative radiation therapy, chemotherapy and surgery except for minor surgery within the last 4 weeks. 3\. Patients using anticoagulant drugs (warfarin, heparin and Direct oral anticoagulants) consistently. 4\. Patients have serious renal disease: creatinine clearance\<30ml/min, or hypersensitivity to CT contrast media. 5\. Patients with active infections. 6\. Pregnant or possibly pregnant women. 7\. Patients with lower limb amputation. 8\. Patients who are inappropriate as a subject of the study judged by the treating physicians or investigator.